Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

TRULICITY® (dulaglutide): Route of Administration

Trulicity (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm.

Dulaglutide - Overview of the Molecule

Trulicity® (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm. It must not be injected intravenously or intramuscularly (Trulicity Package Insert, 2017).

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

The published reference below is available upon request by contacting 1-800-LillyRx.

Reference

Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2017.

Date of Last Review: January 17, 2017

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical